Connect with us

Technology

The Orthopedic Prosthetics Market is projected to grow by USD 871.9 Million (2024-2028), driven by rising trauma cases, accidents, and birth defects, with AI-powered market evolution – Technavio

Published

on

NEW YORK, Oct. 8, 2024 /PRNewswire/ — Report on how AI is driving market transformation – The Global Orthopedic Prosthetics Market size is estimated to grow by USD 871.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.05%  during the forecast period. Growing number of trauma, accident cases, and birth defects is driving market growth, with a trend towards growing focus on customized orthopedic prosthetics. However, high cost of prosthetics  poses a challenge – Key market players include Advanced Arm Dynamics Inc., Arthrex Inc., Artificial Limbs Manufacturing Corp. Of India, B.Braun SE, Blatchford Ltd., Exactech Inc., Fillauer LLC, Globus Medical Inc., Hanger Inc, Johnson and Johnson Services Inc., LeTourneau Prosthetics and Orthotics, Orthotic and Prosthetic Lab Inc, Ossur hf, Ottobock SE and Co. KGaA, RTI Surgical Inc., Smith and Nephew plc, Steeper Inc., Stryker Corp., WillowWood LLC, and Zimmer Biomet Holdings Inc..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report

Orthopedic Prosthetics Market Scope

Report Coverage

Details

Base year

2023

Historic period

2017 – 2021

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.05%

Market growth 2024-2028

USD 871.9 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

5.07

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 33%

Key countries

US, Germany, China, UK, and Canada

Key companies profiled

Advanced Arm Dynamics Inc., Arthrex Inc., Artificial Limbs Manufacturing Corp. Of India, B.Braun SE, Blatchford Ltd., Exactech Inc., Fillauer LLC, Globus Medical Inc., Hanger Inc, Johnson and Johnson Services Inc., LeTourneau Prosthetics and Orthotics, Orthotic and Prosthetic Lab Inc, Ossur hf, Ottobock SE and Co. KGaA, RTI Surgical Inc., Smith and Nephew plc, Steeper Inc., Stryker Corp., WillowWood Global LLC, and Zimmer Biomet Holdings Inc.

Market Driver

Customized orthopedic prosthetics have gained significant attention in the market due to their superior functionality and increasing demand from end-users, particularly athletes and accident victims. Leading companies like Ossur and Ohio Willow Wood are focusing on providing customized prosthetics using advanced technologies such as CAD/CAM and lasers. These technologies enable vendors to manufacture prosthetics that perfectly match the shape of the amputee’s limb, ensuring a better fit and improved performance. Innovations like computer-aided shape modification, 3D scanners, 3D printer integration, and automated carvers further enhance the customization process. Companies such as Vorum offer integrated CAD/CAM solutions to develop customized orthopedic prosthetics, increasing productivity by up to 600%. With over 700 vendors using their CAD/CAM solution, the trend towards customized prosthetics is expected to drive market growth during the forecast period. 

The Orthopedic Prosthetics Market is experiencing significant growth due to increasing trends in accidental injuries and the aging population. Demand for artificial limbs is on the rise as chronic illnesses such as diabetes, osteoarthritis, and obesity become more prevalent. Product innovations in electric prostheses, myoelectric prostheses, and Cheetah sports prosthesis are improving patient comfort and functionality. The burden of osteosarcoma and other bone diseases is driving research and development in material science. Distribution networks are expanding to reach individual patients in remote areas, with public-private funding and regulatory authorities playing crucial roles. Healthcare facilities are integrating Internet of Things technology, including Bluetooth and smartphone connectivity, to enhance patient care and reduce the risk of deep vein thrombosis. However, challenges such as limited infrastructural facilities, hesitation to adopt new technologies, and infection risks remain. The market’s economic well-being is influenced by healthcare budgets, per capita expenditure, and the overweight population. Product innovations and regulatory approvals are essential to address the unique needs of the geriatric population. The reimbursement scenario is evolving, with statistics showing a growing number of orthopedic surgeries and road accidents. The market’s future looks promising as medical science continues to advance, and the Internet penetration rate increases. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

 Market Challenges

The global orthopedic prosthetics market is experiencing steady growth, yet the high cost of prosthetics poses a significant challenge. A basic prosthetic leg can cost up to USD10,000, with advanced prosthetic legs reaching over USD100,000. Electricity-powered prosthetics range between USD40,000 and USD60,000, making them a significant investment. For instance, the Genium X3 prosthetic leg costs approximately USD120,000, while the Michelangelo electronic hand costs around USD60,000. Some companies offer expensive prosthetics to select patients, such as Ottobock Healthcare’s bionic leg for military personnel, priced at USD150,000. Post-surgery care and maintenance, including rehabilitation, further increase the overall cost. Physical therapy sessions cost between USD50 and USD350, while occupational therapy sessions range from USD50 to USD400. The high cost of orthopedic prosthetics can significantly impact the growth of the global market during the forecast period.The Orthopedic Prosthetics Market faces several challenges in the healthcare sector. Healthcare budgets and facilities limit the accessibility of prosthetic devices for individual patients. Hesitation and stigma surrounding their use persist. Infections and injuries require continuous innovation in material science, such as the use of polymer materials. Regulatory authorities and public-private funding play a crucial role in the reimbursement scenario. The obesity and overweight population pose challenges due to the increased demand for Lower Extremity Prosthetics. Trauma cases and road accidents lead to a higher usage of orthopedic prosthetic devices. Product innovations, including Myoelectric prostheses and smartphone connectivity, are essential to meet the evolving needs of patients. Limited infrastructural facilities and the Internet penetration rate impact the distribution and availability of medical equipment. Infections and injuries from vehicles add to the market size. Strategic movements by professionals and product innovations are essential to address the challenges posed by the increasing statistics of Osteoarthritis and orthopedic surgeries. The Internet of Things and smartphone connectivity offer opportunities for remote monitoring and upgrading lifestyles. However, concerns regarding the security of data and potential infections remain. The challenges in the orthopedic prosthetics market require continuous innovation and collaboration between medical science, regulatory authorities, and industry professionals.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This orthopedic prosthetics market report extensively covers market segmentation by  

Product 1.1 Lower extremity orthopedic prosthetics1.2 Upper extremity orthopedic prostheticsTechnology 2.1 Conventional2.2 Electric-powered2.3 HybridGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Lower extremity orthopedic prosthetics-  The Orthopedic Prosthetics Market refers to the industry that produces and distributes artificial limbs and other orthopedic devices. These products cater to individuals with limb loss or limb differences due to various reasons such as trauma, birth defects, or diseases. The market is growing due to an aging population, increasing road accidents, and advancements in technology leading to improved functionality and design of prosthetics. Key players in this market include Otto Bock Healthcare, Hanger Inc., and Ossur. Companies focus on research and development to offer innovative solutions, enhancing user experience and mobility.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

The Orthopedic Prosthetics Market encompasses the production and distribution of orthopedic prosthetic devices, including artificial limbs, used to replace missing body parts due to various conditions such as Orthopedic surgeries, trauma cases from road accidents or vehicle incidents, and accidental injuries. The burden of diseases like osteosarcoma and osteoarthritis fuels the demand for these devices. The usage of prosthetics is increasingly common among individual patients, especially in the aging population and those with low bone density, diabetes, or obesity. Medical science continues to advance, leading to innovations like Cheetah sports prosthesis and electric prostheses. The world population’s increasing size and the resulting rise in the number of patients needing prosthetic devices further boost market growth. Lower Extremity Prosthetics, a significant segment, is expected to witness significant demand due to the high prevalence of injuries affecting the lower limbs.

Market Research Overview

The Orthopedic Prosthetics Market encompasses the production, distribution, and usage of artificial limbs and orthopedic devices designed to replace or support missing or damaged body parts. Factors driving market growth include the increasing burden of chronic illnesses such as diabetes, osteoarthritis, and obesity, as well as accidental injuries and road accidents. The geriatric population and the overweight population are also significant contributors, with the aging population experiencing age-related conditions like bone density loss and the need for orthopedic surgeries. Product innovations in material science, including the use of polymer materials and Bluetooth and smartphone connectivity, are enhancing the comfort and functionality of orthopedic prosthetics. However, challenges such as limited infrastructural facilities, regulatory hurdles, and the stigma surrounding prosthetics usage remain. Market growth is also influenced by economic well-being, healthcare budgets, and the distribution network, with public-private funding playing a crucial role in expanding access to these essential medical devices. The market includes various types of prosthetics, including Lower Extremity Prosthetics, Myoelectric prostheses, and Electric prostheses, catering to individual patient needs. Strategic movements by professionals and regulatory authorities, as well as the impact of healthcare facilities and reimbursement scenarios, are shaping the market landscape. The usage of prosthetics is also influenced by factors such as deep vein thrombosis, infections, and upgrading lifestyles. The Internet of Things and Internet penetration rate are also transforming the market, with Cheetah sports prosthesis and other smart prosthetics offering enhanced functionality and convenience. Despite these opportunities, challenges such as hesitation and the burden of osteosarcoma remain. Overall, the Orthopedic Prosthetics Market is poised for significant growth, driven by the increasing need for these devices to improve patient health and enhance mobility.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ProductLower Extremity Orthopedic ProstheticsUpper Extremity Orthopedic ProstheticsTechnologyConventionalElectric-poweredHybridGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-orthopedic-prosthetics-market-is-projected-to-grow-by-usd-871-9-million-2024-2028-driven-by-rising-trauma-cases-accidents-and-birth-defects-with-ai-powered-market-evolution–technavio-302269667.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Armentum Partners Makes Key Senior Hire in Andrew Fineberg to Expand Royalty Capabilities

Published

on

By

MENLO PARK, Calif., Oct. 8, 2024 /PRNewswire/ — Armentum Partners, the leading investment bank focused exclusively on raising non-dilutive and structured financings for growth stage healthcare and technology companies, is delighted to announce the addition of senior banker, Andrew Fineberg, as a Managing Director. Andrew joins with a long history of successfully advising academic and not-for-profit institutions around the world on pharmaceutical royalty monetization and corporate clients on the full spectrum of non-dilutive and structured financing options. Andrew, who will be based in New York City, joins Armentum Partners from OrbiMed Advisors, LLC, where he was a Managing Director in the Royalty and Credit Opportunities Fund. 

“We are excited to have Andrew join our team. Andrew has a unique and dominant position in the royalty space as one of the most active and well-respected advisors. We believe his experience will allow us to help our academic and corporate clients explore a wider range of non-dilutive and structured financing alternatives,” commented Chris Carthy, Ph.D., Founder and Managing Partner of Armentum Partners. The investment bank now covers all aspects of non-equity financings with a presence in Silicon Valley, New York, Boston, Philadelphia, and Chicago.

On joining, Andrew said “I am thrilled to join Armentum and get back to doing what I enjoy most, delivering royalty solutions to academic institutions and structured financings to companies. I was attracted to Armentum’s market leading position, stellar reputation with investors and clients, and their very experienced senior bankers.” 

Andrew has previously held senior roles at SVB Leerink, MTS Health Partners, Torreya Partners, and Cowen & Company. Andrew is a graduate of the Wharton School at the University of Pennsylvania.

About Armentum Partners

Armentum is a full-service, independent financial advisory firm with over 150 years of combined experience in investment banking, commercial banking and lending, venture financing, private and public equity investing, and business development. While Armentum is full-service, its main focus is raising debt and non-dilutive capital raising solutions primarily for technology and healthcare companies. Armentum’s clients benefit from its sector focus and unique backgrounds in the healthcare and scientific fields, including team members with previous careers in engineering and research. Armentum’s managing partners have been working together over the last decade, bringing consistency to each process, and driving its goal of securing the best structure and cost of non-dilutive capital for clients to best meet their strategic growth needs. The firm has remained incredibly active, having raised $16 billion since inception across 350+ transaction, including $2 billion thus far in 2024. Armentum Partners’ employees are fully Registered Representatives of a FINRA member firm.

Media Contact: Kristina Mourlot, kristina@armentumpartners.com, 312-502-0793

View original content:https://www.prnewswire.com/news-releases/armentum-partners-makes-key-senior-hire-in-andrew-fineberg-to-expand-royalty-capabilities-302270766.html

SOURCE Armentum Partners

Continue Reading

Technology

Rob Renzi Joins Catalyst Solutions as Chief Growth Officer

Published

on

By

Experienced Health Care Leader to Drive Growth

GREENWOOD VILLAGE, Colo., Oct. 8, 2024 /PRNewswire/ — Catalyst Solutions, a leader in innovative solutions to Health Plans, has announced today that Rob Renzi has joined the company as Chief Growth Officer. Renzi brings more than 35 years of leadership experience in sales, business development, and account management in the healthcare industry.

Rachel Spilo, CEO of Catalyst, said, “I’ve known Rob for nearly 20 years. He is exceptionally well-known and well-regarded in our industry. Rob has a proven track record of building and leading sales teams and expanding customer relationships. His extensive knowledge of payer platforms, solutions, and partners will be a tremendous asset to our organization.”

Renzi joins Catalyst from Zelis, a healthcare financial management platform, where he was Senior Vice President of Business Development. Prior to Zelis, he was Senior Vice President and Chief Revenue Officer at Welltok, a SaaS platform for healthcare consumer activation, and was instrumental in Welltok’s sale to Virgin Pulse (now Personify Health). In a 29-year career at TriZetto, one of the industry’s leading claims platforms, he held roles including President of New Business.

Added Renzi, “I love the healthcare technology industry and its commitment to improving people’s lives through innovative solutions, and I have an insatiable passion for being a part of making it better. I’m excited about the opportunity to help Catalyst, its clients, partners, and employees to achieve better health outcomes.”

Added Sas Mukherjee, President of Catalyst, “We are very excited to have Rob lead and accelerate our impressive growth. Rob has a track record of leading earlier waves of growth in adoption of platform and service innovation to health plans. So, it is a testament to the superior value proposition of the solutions from Catalyst that Rob has decided to join us to help Catalyst lead the next wave of innovation and transformation of the industry.”

In his role at Catalyst Solutions, Renzi will lead a team in the pursuit of new clients and securing strategic partnerships to help simplify the complex environment of health benefits and the technology supporting it.  

About Catalyst Solutions: Catalyst Solution’s mission is to help health plans improve health outcomes, improve member and provider experience while reducing medical and administrative costs. We are passionate about making positive and measurable improvements on behalf of the clients we serve and the communities in which we live. With 25 years of deep expertise in outsourced health plan outsourcing, IT, and consulting services, Catalyst delivers comprehensive and scalable solutions that meet the unique needs of payers, and we are committed to exceeding customer expectations by providing unmatched service. To learn more, please visit www.catalystsolutions.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rob-renzi-joins-catalyst-solutions-as-chief-growth-officer-302270771.html

SOURCE Catalyst Solutions

Continue Reading

Technology

AWAK Transforms into Vivance, Unveiling a New Brand Identity

Published

on

By

SINGAPORE, Oct. 9, 2024 /PRNewswire/ — AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding to Vivance. The name, derived from ‘viva’ and ‘advance’, embodies vitality and progress – hallmarks of the company’s commitment to revolutionizing kidney health.

AWAK Technologies was founded with a groundbreaking idea: the development of a wearable dialysis device, Automated Wearable Artificial Kidney (AWAK). As the company continues its mission to transform kidney care, the portfolio has been expanded with products that aim to enhance patient outcomes and quality of life. To reflect this evolution and commitment to innovation, it has rebranded to Vivance – a name that captures its dynamic and forward-thinking approach in managing kidney health.

Suresha Venkataraya, CEO of Vivance, said, “This rebrand reflects how far we’ve come, and where we’re heading. Building on the foundation of our wearable dialysis device, we’ve made significant strides by expanding our portfolio to include cost-effective home modalities and complementary digital offerings. This rebrand reinforces our ultimate mission of treating patients in the comfort of their homes.”

Abel Ang, Chairman of Vivance, added, “We are excited to introduce Vivance to the world. Building on two breakthrough device designations from the FDA, our rebranding accelerates our mission to revolutionize healthcare. This exciting new chapter for the company will see us take patient-centric dialysis from a dream into reality.”

Looking Ahead

As Vivance, the company will continue to refine its brand strategy, product positioning, and approach to market entry, ensuring a strong and strategic alignment with industry needs. The wearable dialysis device is progressing through clinical trials, while additional innovations, such as point-of-care PD fluid generation system, remote monitoring tools and AI prediction models, are in advanced stages of research and development. These products are poised to enter their clinical phases in the near future, reinforcing Vivance’s mission to drive meaningful disruption in the kidney care sector.

Media Contact:

Priyanka Arya
Senior Marketing Manager
+65 6950 5011
priyanka.arya@awak.com 

About Vivance

Vivance, formerly AWAK Technologies, is a pioneering, patient-centric medical technology company with a mission to enhance the lives of people with kidney disease and their caregivers by providing solutions to deliver better outcomes and improve their quality of life.

Headquartered in Singapore with offices in Los Angeles, United States and Bengaluru, India, the company is dedicated to the research, development and marketing of novel technologies in kidney care. 

Logo – https://mma.prnewswire.com/media/2516325/Vivance_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/awak-transforms-into-vivance-unveiling-a-new-brand-identity-302269606.html

Continue Reading

Trending